Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes
Yanping Zheng, Ying Ran, Hongxia Zhang, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 19

Showing 19 citing articles:

Bile acid metabolism and signaling, the microbiota, and metabolic disease
Jingwei Cai, Bipin Rimal, Changtao Jiang, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108238-108238
Open Access | Times Cited: 211
Research progress on the relationship between intestinal microecology and intestinal bowel disease
Qian-Hui Fu, Tianyuan Song, Xiaoqin Ma, et al.
Animal Models and Experimental Medicine (2022) Vol. 5, Iss. 4, pp. 297-310
Open Access | Times Cited: 39
The need for an integrated multi‐OMICs approach in microbiome science in the food system
Ilario Ferrocino, Kalliopi Rantsiou, Ryan McClure, et al.
Comprehensive Reviews in Food Science and Food Safety (2023) Vol. 22, Iss. 2, pp. 1082-1103
Open Access | Times Cited: 29
HLA, gut microbiome and hepatic autoimmunity
Benedetta Terziroli Beretta‐Piccoli, Giorgina Mieli‐Vergani, Diego Vergani
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Primary biliary cholangitis: Insights into genetic susceptibility and systemic manifestations
Yuling Yang, Shujun Zhang
European Journal of Inflammation (2025) Vol. 23
Open Access
Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value
Zhen-Jiao Li, Hong-Zhong Gou, Yulin Zhang, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 44, pp. 6213-6229
Open Access | Times Cited: 15
Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study
Yugang Fu, Jiacheng Li, Yingying Zhu, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
High prevalence of lower limb atherosclerosis is linked with the gut–liver axis in patients with primary biliary cholangitis
Francesca Romana Ponziani, Antonio Nesci, Camilla Caputo, et al.
Liver International (2022) Vol. 43, Iss. 2, pp. 370-380
Open Access | Times Cited: 13
CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
Haize Ge, Wei Wei, Liang Tang, et al.
Medicine (2022) Vol. 101, Iss. 25, pp. e29347-e29347
Open Access | Times Cited: 12
Alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis
Meng Jin, Jinghua Cui, Hui-Juan Ning, et al.
BMC Microbiology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention
Massimiliano Cadamuro, Mario Strazzabosco
Advances in cancer research (2022), pp. 39-73
Closed Access | Times Cited: 6
Gut Microbiome and Liver Diseases from the Perspective of 3PM: The Predictive, Preventive, and Personalized Medicine
Ľubomír Skladaný, T. Köller, Michał Kukla, et al.
Advances in predictive, preventive and personalised medicine (2023), pp. 141-175
Closed Access | Times Cited: 3
Metagenomics and Machine Learning-Based Precision Medicine Approaches for Autoimmune Diseases
Itrat Zehrh, Umme Habiba, Matilde Rosalia Picco, et al.
(2023)
Open Access | Times Cited: 2
Metagenomics and Machine Learning-Based Precision Medicine Approaches for Autoimmune Diseases
Itrat Zehrh, Umme Habiba, Matilde Rosalia Picco, et al.
(2023)
Open Access | Times Cited: 2
Risk Stratification in Primary Biliary Cholangitis
Francesco Martini, Daniele Balducci, Martina Mancinelli, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5713-5713
Open Access | Times Cited: 2
Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis
Zhenhua Ma, Xiaomei Wang, Ruihong Wu, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 39, pp. 5764-5783
Open Access | Times Cited: 4
Effects of Probiotics on Liver Diseases: Current In Vitro and In Vivo Studies
Maryam Sadri, Zahra Shafaghat, Mona Roozbehani, et al.
Probiotics and Antimicrobial Proteins (2024)
Closed Access
Differences in Gut Microbiome Profile between Healthy Children and Children with Inflammatory Bowel Disease and/or Autoimmune Liver Disease: A Case-Control Study
Robert Lopez, Steven T. Leach, Nerissa L. Bowcock, et al.
Pathogens (2023) Vol. 12, Iss. 4, pp. 585-585
Open Access | Times Cited: 1
Causal Effects of Gut Microbiome on Autoimmune Liver Disease: A Two-Sample Mendelian Randomization Study
Yugang Fu, Jiacheng Li, Yingying Zhu, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top